Carvykti was approved by Health Canada in 2023, but has not become available to cancer patients as a deal between the ...
It’s still unclear if U.S. AI companies are overvalued, but some investors are looking for opportunities beyond Silicon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback